Am.  Tour.  Pharm.  ) 
January,  1921.  J 
Correspondence. 
65 
When  the  Washington  conference  had  adjourned  several  mem- 
bers requested  that  this  action  on  Scope  be  reconsidered  by  mail 
and  an  opportunity  was  again  given  to  every  member  of  the  com- 
mittee to  present  arguments.  These  were  published  in  full  in  the 
committee  circulars  and  a  new  vote  taken.  A'gain  the  motions 
were  approved  by  the  committee.  The  practical  operation  of  this 
decision  resulted  in  immediately  placing  before  the  committee  the 
decisions  of  the  Sub-committee  on  Scope.  This  consists  of  a  list 
of  those  substances  now  in  the  U.  S.  P.  IX.,  which  are  approved 
for  admission  and  also  the  names  of  such  new  articles  as  may  be 
deemed  worthy  of  recognition.  Members  of  the  Committee  of 
Revision  are  invited  to  comment  upon  the  reports  on  Scope,  and 
if  there  is  a  question  raised  concerning  the  decisions  of  the  sub- 
committee, the  articles  under  discussion  will  be  reconsidered  by 
all  of  the  physicians  of  the  Revision  Committee,  their  vote  is  to 
be  accepted  as  final.  It  should  be  explained  that  the  Sub-committee 
on  Scope  consists  of  the  seventeen  representatives  nominated  by 
the  medical  members  of  the  convention  and  also  includes  three 
pharmacists.  There  are  at  least  six  additional  physicians  on  the 
Revision  Committee  and  these  will  have  a  vote  on  all  substances 
which  must  be  reconsidered. 
The  reports  of  the  Sub-committee  on  Scope  will  also  be  pub- 
lished in  journals  at  a  suitable  time,  that  physicians  and  pharma- 
cists may  have  an  opportunity  to  express  their  opinion  concerning 
1    the  reported  admissions  or  deletions  and  all  of  these  comments  will 
be  placed  before  the  committee  before  the  final  vote. 
The  motions,  as  will  be  observed,  provide  for  the  original 
decisions  on  therapeutically  useful  substances  through  the  vote  of 
the  Sub-committee  on  Scope,  with  the  final  decision,  if  the  original 
report  is  questioned,  left  to  the  vote  of  the  physicians  of  the  entire 
committee.  In  the  same  manner  the  inclusion  of  those  substances 
of  pharmaceutical  necessity  are  left  to  the  pharmaceutical  members 
of  the  committee  for  final  decision. 
At  the  personal  conferences  the  Revision  Committee  also 
adopted  rules  of  procedure  for  the  conduct  of  business  in  the 
committee,  following  very  closely  the  rules  in  force  during  the  last 
decade. 
Considerable  criticism  had  been  received  concerning  the  use 
of  "mils"  in  the  Pharmacopoeia,  and  as  the  term  had  not  been 
